Cates, CJ
(2011)
Safety of tiotropium: Indirect evidence suggests the Respimat inhaler is riskier than the Handihaler.
BRITISH MEDICAL JOURNAL, 342.
pp. 1-2.
ISSN 0959-8138
https://doi.org/10.1136/bmj.d2970
SGUL Authors: Cates, Christopher Joseph
|
["document_typename_application/pdf; charset=binary" not defined]
Published Version
Available under License St George's repository terms & conditions. Download (743kB) | Preview |
Item Type: | Article |
---|---|
Additional Information: | PubMed ID: 21672998 |
Keywords: | Bronchodilator Agents, Humans, Pulmonary Disease, Chronic Obstructive, Randomized Controlled Trials as Topic, Scopolamine Derivatives, Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine |
SGUL Research Institute / Research Centre: | Academic Structure > Population Health Research Institute (INPH) |
Journal or Publication Title: | BRITISH MEDICAL JOURNAL |
ISSN: | 0959-8138 |
Related URLs: | |
Web of Science ID: | WOS:000291932100001 |
URI: | https://openaccess.sgul.ac.uk/id/eprint/2681 |
Publisher's version: | https://doi.org/10.1136/bmj.d2970 |
Statistics
Item downloaded times since 06 Dec 2012.
Actions (login required)
![]() |
Edit Item |